Burning Rock Biotech Limited (NASDAQ:BNR – Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 54,700 shares, a decrease of 86.4% from the April 30th total of 402,400 shares. Based on an average daily trading volume, of […]
Burning Rock Biotech Limited (NASDAQ:BNR – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 586,700 shares, a decline of 6.4% from the September 15th total of 626,800 shares. Based on an average trading volume of 64,800 […]
Burning Rock Biotech Limited (NASDAQ:BNR – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 665,100 shares, a growth of 9.4% from the May 15th total of 608,200 shares. Currently, 0.8% of the company’s stock are sold short. […]
Diametric Capital LP cut its holdings in Burning Rock Biotech Limited (NASDAQ:BNR – Get Rating) by 71.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 92,204 shares of the company’s stock after selling 227,554 shares during the quarter. Diametric Capital LP’s holdings in Burning Rock Biotech were worth $207,000 as of its most […]
Burning Rock Biotech (NASDAQ:BNR – Get Rating) will be announcing its earnings results before the market opens on Tuesday, March 28th. Analysts expect the company to announce earnings of ($0.32) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Burning Rock Biotech Price […]